Clinical Trial Update: Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating metformin for prevention of oral cancer in patients with oral leukoplakia or erythroplakia; the study is sponsored by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroplakia
• Oral Leukoplakia

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Arizona | Conditions: Erythroplakia, Oral Leukoplakia | Phase 2 | Status: ACTIVE_NOT_RECRUITING